3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gynecologic
1
Conditions
Leukemia, Myeloid, Acute
49
Neoplasm Metastasis
47
Multiple Myeloma
40
Breast Neoplasms
33
Prostatic Neoplasms
31
Colorectal Neoplasms
27
Lymphoma
26
Lung Neoplasms
26
Leukemia, Lymphocytic, Chronic, B-Cell
24
Pancreatic Neoplasms
22
Myelodysplastic Syndromes
22
Lymphoma, Large B-Cell, Diffuse
21
Triple Negative Breast Neoplasms
19
Ovarian Neoplasms
17
Melanoma
17
Carcinoma, Non-Small-Cell Lung
17
Burkitt Lymphoma
17
Precursor Cell Lymphoblastic Leukemia-Lymphoma
15
Carcinoma, Renal Cell
15
Neoplasms
14
Leukemia, Myelomonocytic, Chronic
13
Glioma
13
Neuroblastoma
12
Lymphoma, Mantle-Cell
12
Lymphoma, Follicular
12
Sarcoma
11
Lymphoma, Non-Hodgkin
11
Fallopian Tube Neoplasms
11
Endometrial Neoplasms
11
Myeloproliferative Disorders
10
Interventions
Cisplatin
6
pembrolizumab
5
Nivolumab
5
palbociclib
4
durvalumab
4
Pemetrexed
4
atezolizumab
3
abemaciclib
3
Fulvestrant
3
Carboplatin
3
Anastrozole
3
130-nm albumin-bound paclitaxel
3
selpercatinib
2
ribociclib
2
relatlimab
2
entrectinib
2
cobimetinib
2
capmatinib
2
alectinib
2
Vemurafenib
2
Radiosurgery
2
Paclitaxel
2
Letrozole
2
Gonadotropin-Releasing Hormone
2
Gemcitabine
2
Bevacizumab
2
AZD9833
2
trametinib
1
taletrectinib
1
spartalizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms by Site
×
Biopsy
×
1 year
×
Clear all
NCT06815939
2026-01-29
OPTICS
DL Analytics
Phase NA
Recruiting
10,000 enrolled